Occupational asthma (workplace asthma): diagnosis, examination of the association between disease and occupation, as well as treatment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper is devoted to one of the most common occupational diseases, such as occupational asthma (OA) that occurs under industrial and agricultural production conditions when exposed to high- and low-molecular-weight compounds. It presents the main chemical and biological factors that are etiological factors of OA, as well as the main professions that are susceptible to this disease. The paper formulates the basic principles of the diagnosis of OA, the principles of its treatment, prevention, and examination of the association between disease and occupation, and professional suitability.

Full Text

Restricted Access

About the authors

S. A Babanov

Samara State Medical University, Ministry of Health of Russia

Email: s.a.babanov@mail.ru

L. A Strizhakov

I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

A. G Baikova

Samara State Medical University, Ministry of Health of Russia

M. Yu Vostroknutova

Samara State Medical University, Ministry of Health of Russia

A. S Agarkova

Samara State Medical University, Ministry of Health of Russia

N. A Ostryakova

Samara State Medical University, Ministry of Health of Russia

T. M Kiryushina

Samara State Medical University, Ministry of Health of Russia

References

  1. Профессиональные заболевания органов дыхания. Национальное руководство. Под ред. Н.Ф. Измерова, А.Г. Чучалина. М.: ГЭОТАР-Медиа, 2015; 792 с.
  2. Косарев В.В., Бабанов С.А. Профессиональные болезни. М.: ГЭОТАР-Медиа; 2010; 368 с.
  3. Профессиональная патология. Национальное руководство. Под ред. Н.Ф. Измерова. М.: ГЭОТАР-Медиа, 2011; 784 с.
  4. Саакадзе В.П., Степанов С.А. Профессиональная бронхиальная астма. Саратов, 1989; с. 17-41
  5. GINA Report, Global Strategy for Asthma Management and Prevention. URL: http://www.ginasthma.org
  6. Степанов С.А. К вопросу о природе так называемой «зерновой лихорадки». Казанский медицинский журнал. 1968; 8: 8-13
  7. Maestrelli P., Saetta M., Mapp C. et al. Mechanisms of occupational asthma. Clin Exp Allergy. 1997; 27 (suppl. 1): 47-54. doi: 10.1111/j.1365-2222.1997. tb01826.x
  8. Maestrelli P., del Prete G.F., de Carli M. et al. CD8 Tcell clones producing interleukin5 and interferongamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J. Work Environ Hlth. 1994; 20: 376-81. doi: 10.5271/sjweh.1383
  9. Макова Е.В. Клинические и иммунологические аспекты профессиональной аллергии к натуральному латексу. Автореф. дисс. канд. мед. наук. Самара, 2003; 24 с.
  10. Клинические рекомендации. Бронхиальная астма. Под ред. А.Г. Чучалина. М.: Изд-во Атмосфера, 2008; 224
  11. Косарев В.В., Бабанов С.А. Профессиональные заболевания медицинских работников. Самара: Офорт, 2009; 232 с.
  12. Косарев В.В., Бабанов С.А. Справочник врача-пульмонолога. Ростов-на-Дону: Феникс, 2011; 446 с.
  13. Tilles S.A., Jerath1-Tatum A. Differential diagnosis of occupational asthma. Immunol Allergy Clin N. Am. 2003; 23: 167-76. doi: 10.1016/s0889-8561(02)00089-9
  14. Sastre J., Vandesplas O., Park H.S. Pathogenesis of occupational asthma. Eur Respir J. 2003; 22: 364-67. doi: 10.1183/09031936.03.00045103
  15. Wan H., Winton H.L., Soeller C. et al. Der p1 facilitates transepithelial allergen delivery by disruption of tight functions. J. Clin Invest. 1999; 104: 123-33. doi: 10.1172/JCI5844
  16. Agius R.M., Nee J., Mc Govern B. et al. Structure activity hypotheses in occupational asthma caused by low molecular weight substances. Ann Occup Hyg. 1991; 35: 129-37. doi: 10.1093/annhyg/35.2.129
  17. Козлов В.А., Савченко А.А., Кудрявцев И.В. и др. Клиническая иммунология. Красноярск: Поликор, 2020; 386 с. doi: 10.17513/np.438
  18. Saetta M., Di Stefano A., Maestrelli P. et al. Airway mucos al. inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1992; 145: 160-8. doi: 10.1164/ajrccm/145.1.160
  19. Frew A.J., Chan H., Lam S. et al. Bronchial inflammation in asthma due to western red cedar. Am J. Respir Crit Care Med. 1995; 151: 340-4. DOI: 10.1164/ ajrccm.151.2.7842189
  20. Петровская Е.В. Клинико-иммунологические особенности профессиональной бронхиальной астмы. Автореф. дисс. канд. мед. наук. Самара, 2009; 24 с.
  21. Rabe K.F., Atienza T., Magyar P. et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006; 368 (9537): 744-53. DOI: 10.1016/ S0140-6736(06)69284-2
  22. Vogelmeier C., D’Urzo A., Pauwels R. et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J. 2005; 26 (5): 819-28. doi: 10.1183/09031936.05.00028305
  23. Мухин Н.А., Косарев В.В., Бабанов С.А. и др. Профессиональные болезни. М.: ГЭОТАР-Медиа, 2016; 512 с.
  24. Косарев В.В., Бабанов С.А. Профессиональные заболевания органов дыхания. М.: Инфра-М, 2013; 110 с.
  25. Агафонова О.В., Гриценко Т.А., Богданова Ю.В. и др. Поликлиническая терапия: Учебник. Под ред. Д.И. Давыдкина, Ю.В. Щукина. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2020; 840 с. doi: 10.33029/9704-5545-6-PLT-2020-1-840

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies